BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9892913)

  • 1. Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis.
    Barnetson RS; Marley J; Bullen M; Brookman S; Cowen P; Ellis D; Williams T
    Br J Dermatol; 1998 Oct; 139(4):675-8. PubMed ID: 9892913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of terbinafine (Lamisil) 1% cream given for one week with clotrimazole (Canesten) 1% cream given for four weeks, in the treatment of tinea pedis.
    Evans EG
    Br J Dermatol; 1994 Apr; 130 Suppl 43():12-4. PubMed ID: 8186134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of terbinafine and clotrimazole in treating tinea pedis.
    Evans EG; Dodman B; Williamson DM; Brown GJ; Bowen RG
    BMJ; 1993 Sep; 307(6905):645-7. PubMed ID: 8401048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole.
    Patel A; Brookman SD; Bullen MU; Marley J; Ellis DH; Williams T; Barnetson RS
    Australas J Dermatol; 1999 Nov; 40(4):197-200. PubMed ID: 10570555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial.
    Schopf R; Hettler O; Bräutigam M; Weidinger G; Kaben U; Mayser P; Resl V
    Mycoses; 1999; 42(5-6):415-20. PubMed ID: 10536434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis.
    Suschka S; Fladung B; Merk HF
    Mycoses; 2002 Apr; 45(3-4):91-6. PubMed ID: 12000508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.
    Korting HC; Tietz HJ; Bräutigam M; Mayser P; Rapatz G; Paul C
    Med Mycol; 2001 Aug; 39(4):335-40. PubMed ID: 11556763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG
    Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.
    Bergstresser PR; Elewski B; Hanifin J; Lesher J; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
    J Am Acad Dermatol; 1993 Apr; 28(4):648-51. PubMed ID: 8463471
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials.
    Berman B; Ellis C; Leyden J; Lowe N; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
    J Am Acad Dermatol; 1992 Jun; 26(6):956-60. PubMed ID: 1607415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study.
    De Keyser P; De Backer M; Massart DL; Westelinck KJ
    Br J Dermatol; 1994 Apr; 130 Suppl 43():22-5. PubMed ID: 8186137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seven days of intermittent terbinafine 250 mg treatment in Tinea pedis].
    Hamaguchi T; Takiuchi I
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(2):79-83. PubMed ID: 12040364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical terbinafine. Reduction of duration of therapy for tinea pedis].
    Schmid-Wendtner MH; Korting H
    Hautarzt; 2008 Dec; 59(12):986-91. PubMed ID: 18987841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful 2-week treatment with terbinafine (Lamisil) for moccasin tinea pedis and tinea manuum.
    White JE; Perkins PJ; Evans EG
    Br J Dermatol; 1991 Sep; 125(3):260-2. PubMed ID: 1911319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.
    Elewski B; Bergstresser PR; Hanifin J; Lesher J; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):290-2. PubMed ID: 7829722
    [No Abstract]   [Full Text] [Related]  

  • 20. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.